<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31585536</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>The protective role of microRNA-21 against coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway.</ArticleTitle><Pagination><StartPage>335</StartPage><MedlinePgn>335</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">335</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-019-2077-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">The P38 mitogen-activated protein kinase (MAPK) pathway plays an essential role in CVB3-induced diseases. We previously demonstrated microRNA-21 has potential inhibitory effect on the MAP2K3 which locates upstream of P38 MAPK and was upregulated in mouse hearts upon CVB3 infection. However, the effect and underlying mechanism of miRNA-21 on CVB3 infection remain unclear.</AbstractText><AbstractText Label="METHODS">We detected continuous changes of cellular miRNA-21 and P38 MAPK proteins expression profiling post CVB3 infection in vitro within 12&#xa0;h. P38 MAPK signaling was inhibited by the specific inhibitor, small interfering RNA and miRNA-21 mimic in vitro, CVB3 replication, cell apoptosis rate and proliferation were detected. Viral load in the mice heart, cardiomyocyte apoptosis rate and histological of the heart were also detected in the mice model of viral myocarditis pretreated with miRNA-21-lentivirus.</AbstractText><AbstractText Label="RESULTS">We observed significant upregulation of miRNA-21 expression followed by suppression of the MAP2K3/P38 MAPK signaling in CVB3-infected Hela cells. The inactivation of the MAP2K3/P38 MAPK signaling by P38 MAPK specific inhibitor, small interfering RNA against MAP2K3, or miRNA-21 overexpression significantly inhibited viral progeny release from CVB3-infected cells. Mechanistically, when compared with control miRNA, miRNA-21 showed no effect on capsid protein VP1 expression and viral load within host cells, while significantly reversing CVB3-induced caspase-3 activation and cell apoptosis rate, further promoting proliferation of infected cells, which indicates the inhibitory effect of miRNA-21 on CVB3 progeny release. In the in vivo study, when compared with control miRNA, miRNA-21 pretreatment remarkably inactivated the MAP2K3/P38 MAPK signaling in mice and protected them against CVB3 infection as evidenced by significantly alleviated cell apoptosis rate, reduced viral titers, necrosis in the heart as well as by remarkably prolonged survival time.</AbstractText><AbstractText Label="CONCLUSIONS">miRNA-21 were reverse correlated with P38 MAPK activation post CVB3 infection, miRNA-21 overexpression significantly inhibited viral progeny release and decreased myocytes apoptosis rate in vitro and in vivo, suggesting that miRNA-21 may serve as a potential therapeutic agent against CVB3 infection through targeting the MAP2K3/P38 MAPK signaling.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Immunology, Capital&#xa0;Institute&#xa0;of&#xa0;Pediatrics-Peking&#xa0;University Teaching Hospital, YaBao Road 2, Beijing, 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Zonghui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Immunology, Capital Institute of Pediatrics, YaBao Road 2, Beijing, 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Hailan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Immunology, Capital Institute of Pediatrics, YaBao Road 2, Beijing, 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Sen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Immunology, Capital Institute of Pediatrics, YaBao Road 2, Beijing, 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Miao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Immunology, Capital Institute of Pediatrics, YaBao Road 2, Beijing, 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Immunology, Capital Institute of Pediatrics, YaBao Road 2, Beijing, 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhewei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Immunology, Capital Institute of Pediatrics, YaBao Road 2, Beijing, 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhuo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Immunology, Capital Institute of Pediatrics, YaBao Road 2, Beijing, 100020, China. liuzhuozhuo2005@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jianxin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Immunology, Capital&#xa0;Institute&#xa0;of&#xa0;Pediatrics-Peking&#xa0;University Teaching Hospital, YaBao Road 2, Beijing, 100020, China. jianxinwu_2000@sina.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Immunology, Capital Institute of Pediatrics, YaBao Road 2, Beijing, 100020, China. jianxinwu_2000@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020413">3' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C524940">MIRN21 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D048051">p38 Mitogen-Activated Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.12.2</RegistryNumber><NameOfSubstance UI="D048371">MAP Kinase Kinase 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.12.2</RegistryNumber><NameOfSubstance UI="C482530">MAP2K3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D053148">Caspase 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020413" MajorTopicYN="N">3' Untranslated Regions</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053148" MajorTopicYN="N">Caspase 3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048371" MajorTopicYN="N">MAP Kinase Kinase 3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="Y">MAP Kinase Signaling System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048051" MajorTopicYN="N">p38 Mitogen-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CVB3</Keyword><Keyword MajorTopicYN="N">P38 MAPK</Keyword><Keyword MajorTopicYN="N">Viral release</Keyword><Keyword MajorTopicYN="N">miRNA-21</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31585536</ArticleId><ArticleId IdType="pmc">PMC6778380</ArticleId><ArticleId IdType="doi">10.1186/s12967-019-2077-y</ArticleId><ArticleId IdType="pii">10.1186/s12967-019-2077-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation. 2001;104:1076&#x2013;1082. doi: 10.1161/hc3401.095198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc3401.095198</ArticleId><ArticleId IdType="pubmed">11524405</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Yao H, Xiao Z, Han J, Zou J, Liu Z. Inhibition of IL-2 inducible T-cell kinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection. Mol Immunol. 2014;59:30&#x2013;38. doi: 10.1016/j.molimm.2013.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2013.12.004</ArticleId><ArticleId IdType="pubmed">24462896</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz JC, Hilliard AA, Cooper LT, Jr, Rihal CS. Diagnosis and treatment of viral myocarditis. Mayo Clin Proc. 2009;84:1001&#x2013;1009. doi: 10.1016/S0025-6196(11)60670-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025-6196(11)60670-8</ArticleId><ArticleId IdType="pmc">PMC2770911</ArticleId><ArticleId IdType="pubmed">19880690</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandiarei M, McManus BM. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol. 2008;3:127&#x2013;155. doi: 10.1146/annurev.pathmechdis.3.121806.151534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pathmechdis.3.121806.151534</ArticleId><ArticleId IdType="pubmed">18039131</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Q, Zhang D, Yu H, Xie W, Xin R, Wang L, Xu X, He X, Xiong J, Sheng H, et al. Berberine restricts coxsackievirus B type 3 replication via inhibition of c-jun N-terminal kinase (JNK) and p38 MAPK activation in vitro. Med Sci Monit. 2017;23:1448&#x2013;1455. doi: 10.12659/MSM.899804.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.899804</ArticleId><ArticleId IdType="pmc">PMC5389531</ArticleId><ArticleId IdType="pubmed">28341822</ArticleId></ArticleIdList></Reference><Reference><Citation>Thouverey C, Caverzasio J. Focus on the p38 MAPK signaling pathway in bone development and maintenance. Bonekey Rep. 2015;4:711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4461888</ArticleId><ArticleId IdType="pubmed">26131361</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong J, Shen XH, Chen C, Qiu H, Yang RG. Down-regulation of HIV-1 infection by inhibition of the MAPK signaling pathway. Virol Sin. 2011;26:114&#x2013;122. doi: 10.1007/s12250-011-3184-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-011-3184-y</ArticleId><ArticleId IdType="pmc">PMC8222497</ArticleId><ArticleId IdType="pubmed">21468934</ArticleId></ArticleIdList></Reference><Reference><Citation>Steer SA, Moran JM, Christmann BS, Maggi LB, Jr, Corbett JA. Role of MAPK in the regulation of double-stranded RNA- and encephalomyocarditis virus-induced cyclooxygenase-2 expression by macrophages. J Immunol. 2006;177:3413&#x2013;3420. doi: 10.4049/jimmunol.177.5.3413.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.5.3413</ArticleId><ArticleId IdType="pubmed">16920983</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaziani A, Alisi A, Sanna D, Balsano C. Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1. J Biol Chem. 2006;281:10983&#x2013;10989. doi: 10.1074/jbc.M512536200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M512536200</ArticleId><ArticleId IdType="pubmed">16446363</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillis PA, Okagaki LH, Rice SA. Herpes simplex virus type 1 ICP27 induces p38 mitogen-activated protein kinase signaling and apoptosis in HeLa cells. J Virol. 2009;83:1767&#x2013;1777. doi: 10.1128/JVI.01944-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01944-08</ArticleId><ArticleId IdType="pmc">PMC2643765</ArticleId><ArticleId IdType="pubmed">19073744</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. JNK and PI3&#xa0;k/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells. Biochim Biophys Acta. 2005;1741:4&#x2013;10. doi: 10.1016/j.bbadis.2005.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2005.04.004</ArticleId><ArticleId IdType="pmc">PMC7125767</ArticleId><ArticleId IdType="pubmed">15916886</ArticleId></ArticleIdList></Reference><Reference><Citation>Si X, Luo H, Morgan A, Zhang J, Wong J, Yuan J, Esfandiarei M, Gao G, Cheung C, McManus BM. Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release. J Virol. 2005;79:13875&#x2013;13881. doi: 10.1128/JVI.79.22.13875-13881.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.22.13875-13881.2005</ArticleId><ArticleId IdType="pmc">PMC1280244</ArticleId><ArticleId IdType="pubmed">16254323</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchant D, Dou Y, Luo H, Garmaroudi FS, McDonough JE, Si X, Walker E, Luo Z, Arner A, Hegele RG, et al. Bosentan enhances viral load via endothelin-1 receptor type-A-mediated p38 mitogen-activated protein kinase activation while improving cardiac function during coxsackievirus-induced myocarditis. Circ Res. 2009;104:813&#x2013;821. doi: 10.1161/CIRCRESAHA.108.191171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.108.191171</ArticleId><ArticleId IdType="pubmed">19213955</ArticleId></ArticleIdList></Reference><Reference><Citation>Derijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ, Davis RJ. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 1995;267:682&#x2013;685. doi: 10.1126/science.7839144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7839144</ArticleId><ArticleId IdType="pubmed">7839144</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson RA, Huong SM, Huang ES. Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. J Virol. 2000;74:1158&#x2013;1167. doi: 10.1128/JVI.74.3.1158-1167.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.3.1158-1167.2000</ArticleId><ArticleId IdType="pmc">PMC111450</ArticleId><ArticleId IdType="pubmed">10627526</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev. 2015;87:3&#x2013;14. doi: 10.1016/j.addr.2015.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2015.05.001</ArticleId><ArticleId IdType="pmc">PMC4504744</ArticleId><ArticleId IdType="pubmed">25979468</ArticleId></ArticleIdList></Reference><Reference><Citation>Skalsky RL, Cullen BR. Viruses, microRNAs, and host interactions. Annu Rev Microbiol. 2010;64:123&#x2013;141. doi: 10.1146/annurev.micro.112408.134243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.112408.134243</ArticleId><ArticleId IdType="pmc">PMC3621958</ArticleId><ArticleId IdType="pubmed">20477536</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Haecker I, Yang Y, Gao SJ, Renne R. gamma-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis. Curr Opin Virol. 2013;3:266&#x2013;275. doi: 10.1016/j.coviro.2013.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2013.05.013</ArticleId><ArticleId IdType="pmc">PMC3879080</ArticleId><ArticleId IdType="pubmed">23743127</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell. 2009;34:696&#x2013;709. doi: 10.1016/j.molcel.2009.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2009.06.003</ArticleId><ArticleId IdType="pmc">PMC2763548</ArticleId><ArticleId IdType="pubmed">19560422</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan X, Li S, Holmes JA, Tu Z, Li Y, Cai D, Liu X, Li W, Yang C, Jiao B, et al. MicroRNA 130a regulates both hepatitis C virus and hepatitis B virus replication through a central metabolic pathway. J Virol. 2018 doi: 10.1128/JVI.02009-17c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02009-17c</ArticleId><ArticleId IdType="pmc">PMC5972888</ArticleId><ArticleId IdType="pubmed">29321333</ArticleId></ArticleIdList></Reference><Reference><Citation>McCaskill JL, Ressel S, Alber A, Redford J, Power UF, Schwarze J, Dutia BM, Buck AH. Broad-spectrum inhibition of respiratory virus infection by microRNA mimics targeting p38 MAPK signaling. Mol Ther Nucleic Acids. 2017;7:256&#x2013;266. doi: 10.1016/j.omtn.2017.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2017.03.008</ArticleId><ArticleId IdType="pmc">PMC5415959</ArticleId><ArticleId IdType="pubmed">28624201</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Xiao Z, He F, Zou J, Wu S, Liu Z. MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis. Intervirology. 2013;56:104&#x2013;113. doi: 10.1159/000343750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000343750</ArticleId><ArticleId IdType="pubmed">23183417</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Zhang C. MicroRNA-21 in cardiovascular disease. J Cardiovasc Transl Res. 2010;3:251&#x2013;255. doi: 10.1007/s12265-010-9169-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12265-010-9169-7</ArticleId><ArticleId IdType="pmc">PMC3611957</ArticleId><ArticleId IdType="pubmed">20560046</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, Yan L, Malhotra A, Vatner D, Abdellatif M. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell. 2008;19:3272&#x2013;3282. doi: 10.1091/mbc.e08-02-0159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e08-02-0159</ArticleId><ArticleId IdType="pmc">PMC2488276</ArticleId><ArticleId IdType="pubmed">18508928</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J, Chen H, Ge D, Xu Y, Xu H, Yang Y, Gu M, Zhou Y, Zhu J, Ge T, et al. Mir-21 promotes cardiac fibrosis after myocardial infarction via targeting Smad7. Cell Physiol Biochem. 2017;42:2207&#x2013;2219. doi: 10.1159/000479995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000479995</ArticleId><ArticleId IdType="pubmed">28817807</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X, Wang D, Krall TJ, Delphin ES, Zhang C. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem. 2009;284:29514&#x2013;29525. doi: 10.1074/jbc.M109.027896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.027896</ArticleId><ArticleId IdType="pmc">PMC2785585</ArticleId><ArticleId IdType="pubmed">19706597</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G, Zhang Y, Wei J, Jia W, Ge Z, Zhang Z, Liu X. MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3. BMC Cancer. 2013;13:469. doi: 10.1186/1471-2407-13-469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2407-13-469</ArticleId><ArticleId IdType="pmc">PMC3852118</ArticleId><ArticleId IdType="pubmed">24112539</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Yao H, Wang J, Xiao Z, Xin L, Liu Z, Ma X, Sun J, Jin Q, Liu Z. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice. J Virol. 2015;89:908&#x2013;916. doi: 10.1128/JVI.02933-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02933-14</ArticleId><ArticleId IdType="pmc">PMC4300646</ArticleId><ArticleId IdType="pubmed">25339771</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H, Zhang Y, He F, Wang C, Xiao Z, Zou J, Wang F, Liu Z. Short hairpin RNA targeting 2B gene of coxsackievirus B3 exhibits potential antiviral effects both in vitro and in vivo. BMC Infect Dis. 2012;12:177. doi: 10.1186/1471-2334-12-177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-12-177</ArticleId><ArticleId IdType="pmc">PMC3482581</ArticleId><ArticleId IdType="pubmed">22863145</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinmann E, Doerrbecker J, Friesland M, Riebesehl N, Ginkel C, Hillung J, Gentzsch J, Lauber C, Brown R, Frentzen A, et al. Characterization of hepatitis C virus intra- and intergenotypic chimeras reveals a role of the glycoproteins in virus envelopment. J Virol. 2013;87:13297&#x2013;13306. doi: 10.1128/JVI.01708-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01708-13</ArticleId><ArticleId IdType="pmc">PMC3838269</ArticleId><ArticleId IdType="pubmed">24089562</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin L, Ma X, Xiao Z, Yao H, Liu Z. Coxsackievirus B3 induces autophagy in HeLa cells via the AMPK/MEK/ERK and Ras/Raf/MEK/ERK signaling pathways. Infect Genet Evol. 2015;36:46&#x2013;54. doi: 10.1016/j.meegid.2015.08.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2015.08.026</ArticleId><ArticleId IdType="pubmed">26305625</ArticleId></ArticleIdList></Reference><Reference><Citation>Carthy CM, Granville DJ, Watson KA, Anderson DR, Wilson JE, Yang D, Hunt DW, McManus BM. Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol. 1998;72:7669&#x2013;7675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110038</ArticleId><ArticleId IdType="pubmed">9696873</ArticleId></ArticleIdList></Reference><Reference><Citation>Carthy CM, Yanagawa B, Luo H, Granville DJ, Yang D, Cheung P, Cheung C, Esfandiarei M, Rudin CM, Thompson CB, et al. Bcl-2 and Bcl-xL overexpression inhibits cytochrome c release, activation of multiple caspases, and virus release following coxsackievirus B3 infection. Virology. 2003;313:147&#x2013;157. doi: 10.1016/S0042-6822(03)00242-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0042-6822(03)00242-3</ArticleId><ArticleId IdType="pubmed">12951029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 2004;23:2838&#x2013;2849. doi: 10.1038/sj.onc.1207556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1207556</ArticleId><ArticleId IdType="pubmed">15077147</ArticleId></ArticleIdList></Reference><Reference><Citation>Pin AL, Houle F, Guillonneau M, Paquet ER, Simard MJ, Huot J. miR-20a represses endothelial cell migration by targeting MKK3 and inhibiting p38 MAP kinase activation in response to VEGF. Angiogenesis. 2012;15:593&#x2013;608. doi: 10.1007/s10456-012-9283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-012-9283-z</ArticleId><ArticleId IdType="pubmed">22696064</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Xia Y, Huang S, Liu F, Ying Y, Xu Q, Liu X, Jin G, Papasian CJ, Chen J, et al. Identification of the interaction of VP1 with GM130 which may implicate in the pathogenesis of CVB3-induced acute pancreatitis. Sci Rep. 2015;5:13324. doi: 10.1038/srep13324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13324</ArticleId><ArticleId IdType="pmc">PMC4551966</ArticleId><ArticleId IdType="pubmed">26314804</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Su Y, Yu Y, Yu Y, Wang X, Zou Y, Ge J, Chen R. Dual roles of calpain in facilitating Coxsackievirus B3 replication and prompting inflammation in acute myocarditis. Int J Cardiol. 2016;221:1123&#x2013;1131. doi: 10.1016/j.ijcard.2016.07.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.07.121</ArticleId><ArticleId IdType="pmc">PMC7114300</ArticleId><ArticleId IdType="pubmed">27472894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X, Zhang HM, Qiu Y, Hanson PJ, Hemida MG, Wei W, Hoodless PA, Chu F, Yang D. Coxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components. PLoS Pathog. 2014;10:e1004070. doi: 10.1371/journal.ppat.1004070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004070</ArticleId><ArticleId IdType="pmc">PMC3983067</ArticleId><ArticleId IdType="pubmed">24722419</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>